Establishment of quantitative and consistent in vitro skeletal muscle pathological models of myotonic dystrophy type 1 using patient-derived iPSCs
Abstract Myotonic dystrophy type 1 (DM1) is caused by expanded CTG repeats (CTGexp) in the dystrophia myotonica protein kinase (DMPK) gene, and the transcription products, expanded CUG repeats, sequester muscleblind like splicing regulator 1 (MBNL1), resulting in the nuclear MBNL1 aggregation in the...
Main Authors: | Ryu Kawada, Tatsuya Jonouchi, Akihiro Kagita, Masae Sato, Akitsu Hotta, Hidetoshi Sakurai |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-01-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-26614-z |
Similar Items
-
Generation of a transgene-free iPSC line and genetically modified line from a facioscapulohumeral muscular dystrophy type 2 (FSHD2) patient with SMCHD1 p.Lys607Ter mutation
by: Mitsuru Sasaki-Honda, et al.
Published: (2020-08-01) -
A muscle fatigue-like contractile decline was recapitulated using skeletal myotubes from Duchenne muscular dystrophy patient-derived iPSCs
by: Tomoya Uchimura, et al.
Published: (2021-06-01) -
Generation and Neuronal Differentiation of hiPSCs From Patients With Myotonic Dystrophy Type 2
by: Paola Spitalieri, et al.
Published: (2018-07-01) -
TNNT2 Missplicing in Skeletal Muscle as a Cardiac Biomarker in Myotonic Dystrophy Type 1 but Not in Myotonic Dystrophy Type 2
by: Francesca Bosè, et al.
Published: (2019-09-01) -
Simple and efficient differentiation of human iPSCs into contractible skeletal muscles for muscular disease modeling
by: Muhammad Irfanur Rashid, et al.
Published: (2023-05-01)